by Pill Pals Customer Service | May 16, 2025 | News
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA Sarah...
by Pill Pals Customer Service | May 16, 2025 | News
Spotlight Events & Announcements Surrogate Endpoint (SE) Table UpdateThe SE Table has been updated to reflect surrogate endpoints which were the basis of approval or licensure (as applicable) of a drug or a biological product” under both accelerated and...
by Pill Pals Customer Service | May 16, 2025 | News
NCTR’s annual report summarizes the key accomplishments for each research division for the reported year. The report includes ongoing research project information, research collaboration highlights, and ongoing initiatives. Links and references to published...
by Pill Pals Customer Service | May 16, 2025 | News
Giardia intestinalis (G. lamblia, G. duodenalis) is an intestinal protozoal pathogen found worldwide; the highest incidence occurs in developing countries. For decades, the first-line treatment for giardiasis has been the 5-nitroimidazoles, such as metronidazole and...
by Pill Pals Customer Service | May 15, 2025 | News
Delivery Method: VIA UNITED PARCEL SERVICE AND VIA E-MAIL Reference #: 25-HFD-45-04-01 Product: Drugs Recipient: Nana Barseghian, M.D. 19875 Nordhoff StreetNorthridge, CA 91324United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States...
by Pill Pals Customer Service | May 15, 2025 | News
Opioid addiction and abuse is an immense public health crisis and addressing it is one of the FDA’s highest priorities. In 2019, an average of 38 people died each day from overdoses involving prescription opioids, totaling more than 14,000 deaths. Provisional data...
by Pill Pals Customer Service | May 15, 2025 | News
On May 15, 2025, the Food and Drug Administration approved retifanlimab-dlwr (Zynyz, Incyte Corporation) with carboplatin and paclitaxel for the first-line treatment of adults with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal...
by Pill Pals Customer Service | May 15, 2025 | News
FDA is warning consumers not to purchase or use Umary and Amazy products, marketed as dietary supplements, as they may be harmful to your health. These products are promoted to treat pain and other conditions. FDA laboratory testing found certain Umary and Amazy...
by Pill Pals Customer Service | May 15, 2025 | News
FDA has reevaluated data supporting amoxicillin/clavulanate breakpoints against Haemophilus influenzae. The review included a publication describing the Clinical and Laboratory Standards Institute (CLSI) rationale for revision of the amoxicillin/clavulanate...
Lady Like Style Apron
Price range: $11.99 through $15.99
Malaysian Blonde Human Hair Weave
Price range: $43.99 through $321.99
Electric Plastic Teeth Scaler
Price range: $7.99 through $11.99
High Strength 3D Printing Pen PLA Filament
Price range: $18.99 through $28.99
Smartphone Virtual Reality VR Headset
Price range: $16.99 through $28.99